<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Helwick, Caroline</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Bolton, James</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Risk of Low Bone Mineral Density with Psychotropic Drugs</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-15</style></pages><abstract><style  face="normal" font="default" size="100%">The use of certain psychotropic medications may be enhancing an already high underlying risk for osteoporosis, according to several studies. Psychotropic agents have been linked to fractures, and antidepressants have been associated with low bone mineral density. The studies that were presented validate these earlier findings and suggest that many patients may already be at high risk for bone disease.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>